DocGo reported a strong first quarter in 2022, with revenue increasing by 137% compared to the previous year. The company is transitioning from COVID-related services to longer-term, non-COVID work and expanding its geographic reach. They generated strong net income and cash flow, and expect to see continued improvements in profitability over time.
Revenue increased by 137% compared to the year-ago period.
The company is transitioning from Covid-related services to longer term non-Covid related work.
DocGo is expanding its breadth and geographic reach, adding new services in new states.
The company generated strong net income and cash flow.
The company is reiterating its prior revenue guidance for fiscal year 2022 of approximately $400-420 million and Adjusted EBITDA is anticipated to be approximately $35-41 million for 2022.
Analyze how earnings announcements historically affect stock price performance